Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 822

1.

Histopathology, ultrastructure, and clinical phenotypes in thin glomerular basement membrane disease variants.

Liapis H, Gökden N, Hmiel P, Miner JH.

Hum Pathol. 2002 Aug;33(8):836-45.

PMID:
12203217
2.

Comparison of alpha5(IV) collagen chain expression in skin with disease severity in women with X-linked Alport syndrome.

Nakanishi K, Iijima K, Kuroda N, Inoue Y, Sado Y, Nakamura H, Yoshikawa N.

J Am Soc Nephrol. 1998 Aug;9(8):1433-40.

3.

Alport syndrome. An inherited disorder of renal, ocular, and cochlear basement membranes.

Kashtan CE.

Medicine (Baltimore). 1999 Sep;78(5):338-60. Review.

4.

Thin glomerular basement membrane disease: clinical significance of a morphological diagnosis--a collaborative study of the Italian Renal Immunopathology Group.

Frascà GM, Onetti-Muda A, Mari F, Longo I, Scala E, Pescucci C, Roccatello D, Alpa M, Coppo R, Li Volti G, Feriozzi S, Bergesio F, Schena FP, Renieri A; Italian Renal Immunopathology Group.

Nephrol Dial Transplant. 2005 Mar;20(3):545-51. Epub 2004 Dec 23.

PMID:
15618242
5.

A clinicopathological study of Alport syndrome and detection of type IV collagen chains in Alport patients.

Chen N, Pan X, Ren H, Dong D.

Chin Med J (Engl). 1998 Sep;111(9):797-802.

PMID:
11155669
6.

Type IV collagen alpha 5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody.

Yoshioka K, Hino S, Takemura T, Maki S, Wieslander J, Takekoshi Y, Makino H, Kagawa M, Sado Y, Kashtan CE.

Am J Pathol. 1994 May;144(5):986-96.

7.

Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis.

Pierides A, Voskarides K, Athanasiou Y, Ioannou K, Damianou L, Arsali M, Zavros M, Pierides M, Vargemezis V, Patsias C, Zouvani I, Elia A, Kyriacou K, Deltas C.

Nephrol Dial Transplant. 2009 Sep;24(9):2721-9. doi: 10.1093/ndt/gfp158. Epub 2009 Apr 8.

PMID:
19357112
8.

[Collagen type IV nephropathy: from thin basement membrane nephropathy to Alport syndrome].

Endreffy E, Ondrik Z, Kemény E, Vas Z, Maróti Z, Lencse G, Bereczki C, Haszon I, Túri S, Iványi B.

Orv Hetil. 2005 Dec 25;146(52):2647-53. Hungarian.

PMID:
16468607
9.

X-linked Alport syndrome in females.

Meleg-Smith S, Magliato S, Cheles M, Garola RE, Kashtan CE.

Hum Pathol. 1998 Apr;29(4):404-8.

PMID:
9563792
10.

Distribution of alpha-chains of type IV collagen in glomerular basement membranes with ultrastructural alterations suggestive of Alport syndrome.

Barsotti P, Muda AO, Mazzucco G, Massella L, Basolo B, De Marchi M, Rizzoni G, Monga G, Faraggiana T.

Nephrol Dial Transplant. 2001 May;16(5):945-52.

PMID:
11328899
11.
12.

Alport syndrome and thin basement membrane nephropathy.

Thorner PS.

Nephron Clin Pract. 2007;106(2):c82-8. Epub 2007 Jun 6. Review.

PMID:
17570934
13.

[Collagen IV (alpha3-alpha4) nephropathy].

Torra R, Tazón B, Ars E, Ballarín J.

Nefrologia. 2005;25 Suppl 2:29-32. Spanish.

14.

Alport syndrome. Molecular genetic aspects.

Hertz JM.

Dan Med Bull. 2009 Aug;56(3):105-52.

PMID:
19728970
15.

Alport syndrome. A review of the ocular manifestations.

Colville DJ, Savige J.

Ophthalmic Genet. 1997 Dec;18(4):161-73. Review.

PMID:
9457747
17.

Childhood thin GBM disease: review of 22 children with family studies and long-term follow-up.

Carasi C, Van't Hoff WG, Rees L, Risdon RA, Trompeter RS, Dillon MJ.

Pediatr Nephrol. 2005 Aug;20(8):1098-105. Epub 2005 Jun 7.

PMID:
15940548
18.

Abnormally thin glomerular basement membrane and the Goodpasture epitope.

Pettersson E, Törnroth T, Wieslander J.

Clin Nephrol. 1990 Mar;33(3):105-9.

PMID:
2182229
19.

[Alport syndrome or progressive hereditary nephritis with hearing loss].

Gubler MC, Heidet L, Antignac C.

Nephrol Ther. 2007 Jun;3(3):113-20. Epub 2007 May 8. French.

PMID:
17540313
20.

Supplemental Content

Support Center